Non-neoplastic and neoplastic disease of the thyroid gland Cytomorphologic and immunocytochemical evaluation of FNAs of thyroid lesions for the clinical management of thyroid nodules
Immunocytochemistry In Collaboration
Molecular testing for diagnostic and predictive markers of thyroid carcinoma
AUS
Ali SZ, Cibas ES. The Bethesda system for reporting thyroid cytopathology. Definitions, criteria and explanatory notes. Springer Science + Business Media, LLC, 2010
Follicular Neoplasm
Indeterminate Categories
AUS/FLUS: paucicellular aspirate, focal cytologic/architectural atypia Follicular neoplasm/Suspicious for a follicular neoplasm
Cannot distinguish follicular adenoma from follicular carcinoma Differential includes follicular variant of papillary thyroid carcinoma
Research Implications
Provide additional relevant information for the management of thyroid nodules to clinicians and surgeons without the need to obtain additional material Potentially decrease the number of thyroid aspirates diagnosed as AUS/FLUS or Follicular Neoplasm/Suspicious for a Follicular Neoplasm according to the Bethesda System for reporting thyroid cytopathology Reduce the morbidity of patients with thyroid nodules by placing them into a more relevant category
Future Directions
Use existing archival cytology resources as source of diagnostic and predictive molecular markers in thyroid cytology, including novel techniques
Laser capture microdissection (LCM) of single cells or a small group of cells for next generation sequencing (NGS) analysis
Apply LCM and NGS analysis of archival cytology slides to diseases from other organs/systems, including those where aspirates are often used for the initial diagnosis
Lung Pancreas
Collaborators
Laboratory of Pathology
Mark Roth, M.D. Mark Raffeld, M.D.
Intramural
Francesco Celi, M.D. (NIDDK) Monica Skarulis, M.D. (NIDDK)